Nutrabiovis
Gut Health 4 min read

Saccharomyces boulardii: Yeast Probiotic Ingredient

Saccharomyces boulardii is a yeast-based probiotic, not a bacterium, studied in relation to gut health functionality. Here are its traits, CFU design, and OEM considerations from an ingredient standpoint.

Saccharomyces boulardii: Yeast Probiotic Ingredient

Saccharomyces boulardii holds a unique position as a yeast-based probiotic rather than a bacterium like Lactobacillus. Because yeast is less affected when used alongside antibiotics, it enables differentiated concepts and draws attention in gut-health product development.

Yeast Probiotic Ingredient Overview

Raw materials differ by form.

  • Freeze-dried powder: Easy to standardize for CFU and suited to capsules and sticks.
  • Stabilized coated form: Processing applied to raise survival during storage and distribution.

As a yeast, its CFU labeling and stability design differ from bacterial probiotics.

Mechanism (Research Perspective)

Saccharomyces boulardii has been studied for pathways related to maintaining the gut environment. A review of Saccharomyces boulardii summarizes the traits of yeast probiotics and related gut research. The WHO/FAO guidelines on probiotics state that strain identification and guaranteed viable counts are central to quality.

Simplified diagram showing Saccharomyces boulardii yeast transiting the gut and engaging pathways that maintain the gut environment
Simplified diagram showing Saccharomyces boulardii yeast transiting the gut and engaging pathways that maintain the gut environment

Dosing, CFU, and Specification

Maintaining the guaranteed count through end of shelf life is central. Consider the following in product design.

  1. Overage design against end-of-shelf-life guaranteed CFU
  2. Survival by temperature/humidity and labeled storage conditions
  3. Quality control based on strain identification and CoA
Key takeaway: Saccharomyces boulardii is a yeast-based probiotic; strain identification and end-of-shelf-life guaranteed count with stability design drive quality.
Illustrated comparison table of freeze-dried powder vs. stabilized coated boulardii by count stability and format suitability
Illustrated comparison table of freeze-dried powder vs. stabilized coated boulardii by count stability and format suitability

OEM Formulation Considerations

The focus is count assurance and stability.

  • Standardization: Strain identification and end-of-shelf-life guaranteed CFU
  • Sourcing: Yeast-origin traceability aligned with vegan and allergen positioning
  • Certification: HACCP/GMP compliance and CoA
  • Combination design: Blends with prebiotics and bacterial probiotics

Ingredient Inquiry

Review specs by form in the [ingredient catalog](/catalog), shape concepts in [formulation curation](/curation), and request quotes via [RFQ](/rfq).

#사카로마이세스 보울라디#효모 프로바이오틱스#장 건강#프로바이오틱스#건강기능식품 원료

Building a Gut Health product?

We connect you to ingredient curation and OEM consultation for this category.

Frequently asked questions

How does Saccharomyces boulardii differ from bacterial probiotics?

It is yeast-based rather than bacterial, so it is less affected by antibiotics and uses different count-labeling and stability design. This can serve as a concept differentiator.

How is CFU labeled?

It is labeled by the guaranteed count through end of shelf life, with manufacturing overage designed to meet it. Review alongside storage conditions.

Can gut-health functionality be claimed?

It can be claimed cautiously within the approved functionality scope; statements implying disease prevention or treatment are prohibited.

References

This content is for informational purposes only and does not guarantee the prevention or treatment of any disease. It references the following authoritative sources.